Αποτελέσματα Αναζήτησης
23 Αυγ 2018 · New modalities currently in testing include wearable (WAKs) and implantable artificial kidneys (IAKs). The automated WAK (AWAK) and WAK are devices that have undergone small trials in humans. Additional study is needed before regulatory approval, coverage decisions, and widespread clinical implementation.
- What Are The Data
Patients with non–dialysis-dependent chronic kidney disease...
- Clinical Course of a Patient With Kidney Failure Due to Isolated Bilateral Renal Extramedullary Plasmacytomas
Transverse and sagittal real-time sonograms of the...
- What Are The Data
The most effective kidney replacement therapy (KRT) is a kidney transplant.
5 Ιαν 2024 · This review aims to analyze the state of the art in this particular field of kidney replacement therapy to highlight the current limitations and possible future technology developments to create implanted and wearable organs capable of treating ESKD with artificial organs that can replicate all native kidneys functions.
31 Μαΐ 2012 · However, recent data suggest that living donor kidneys might be the best treatment option for elderly transplant recipients, just as it is for younger individuals. Gill et al 8 examined outcomes for transplant recipients older than 60 years by donor age (younger [≤55 years] or older [>55 years]) and source (living or deceased).
However, kidney transplantation could be a useful option in cases of selected patients of older age. Aim. To compare the evolution of kidney transplant recipients older than 70 years (R>70) with patients younger than 70 years (R<70) in our series. Material and Methods. We analyzed 889 kidney trasplants adult recipients.
18 Ιουλ 2017 · If you are age 65 or older and in need of a kidney transplant, or a caregiver of someone who is, here are three key factors to keep in mind as you begin on your journey to transplantation. Thorough evaluation is imperative for determining whether or not you are well-suited for transplant.
1 Αυγ 2012 · We illustrate the use of this framework by applying it to three key end-stage renal disease decisions in older patients with varying life expectancy: choice of dialysis modality, choice of vascular access for hemodialysis, and referral for kidney transplantation.
